Dr. Novick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Cedar Ln
2B
Teaneck, NJ 07666Phone+1 516-974-4511Fax+1 833-582-0426
Summary
- Dr. Andrew Mark Novick is a board certified neurologist and board certified sleep medicine physician. He currently works as an emergency neurologist and neurohospitalist through virtual tele-acute care medicine. Dr. Novick has medical licensure in 35 states, and provides care to 320 hospitals nationwide.
Education & Training
- NYU Grossman Long Island School of MedicineFellowship, Sleep Medicine, 2020 - 2021
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Neurology, 2017 - 2020
- Saint Peter's University Hospital/Rutgers Robert Wood Johnson Medical SchoolInternship, Internal Medicine, 2016 - 2017
- Touro College of Osteopathic MedicineClass of 2016
Certifications & Licensure
- NM State License 2024 - 2027
- ND State License 2021 - 2026
- CA State License 2022 - 2026
- NE State License 2021 - 2026
- FL State License 2021 - 2026
- VT State License 2024 - 2026
- VA State License 2021 - 2026
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
- Join now to see all
Publications & Presentations
PubMed
- 91 citationsRenal artery pseudoaneurysm after partial nephrectomy: three case reports and a literature reviewJustin M. Albani, Andrew C. Novick
Urology. 2003-08-01 - 315 citationsKidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine.Stuart M. Flechner, David A. Goldfarb, Charles S. Modlin, Jingyuan Feng, Venkatesh Krishnamurthi
Transplantation. 2002-10-27 - 603 citationsThe mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.Jonathan M. Shillingford, Noel S. Murcia, Claire H. Larson, Seng Hui Low, Ryan C. Hedgepeth
Proceedings of the National Academy of Sciences of the United States of America. 2006-04-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: